Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Spriggs

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Journal of Virology|September 1, 1986
Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic mapM K Spriggs, P L Collins
Human Molecular Genetics|June 1, 1993
Dinucleotide repeat polymorphism in the human CD40 ligand geneR C Allen, M K Spriggs, J W Belmont
The Journal of General Virology|May 1, 1987
Sequence analysis of the matrix protein gene of human parainfluenza virus type 3: extensive sequence homology among paramyxovirusesM K Spriggs, P R Johnson, P L Collins
Journal of Clinical Immunology|November 1, 1993
The biology of the human ligand for CD40M K Spriggs, W C Fanslow, R J Armitage, et al.
Immunology Today|November 1, 1993
CD40 ligand and its role in X-linked hyper-IgM syndromeR E Callard, R J Armitage, W C Fanslow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1993
Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokinesR J Armitage, B M Macduff, M K Spriggs, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteinsP R Johnson, M K Spriggs, R A Olmsted, et al.
Journal of Virology|April 1, 1988
Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infectionM K Spriggs, P L Collins, E Tierney, et al.
Virology|July 15, 1986
Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxovirusesM K Spriggs, R A Olmsted, S Venkatesan, et al.
Journal of Virology|November 1, 1987
Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunityM K Spriggs, B R Murphy, G A Prince, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of Virology|September 1, 1986
Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic mapM K Spriggs, P L Collins
Human Molecular Genetics|June 1, 1993
Dinucleotide repeat polymorphism in the human CD40 ligand geneR C Allen, M K Spriggs, J W Belmont
The Journal of General Virology|May 1, 1987
Sequence analysis of the matrix protein gene of human parainfluenza virus type 3: extensive sequence homology among paramyxovirusesM K Spriggs, P R Johnson, P L Collins
Journal of Clinical Immunology|November 1, 1993
The biology of the human ligand for CD40M K Spriggs, W C Fanslow, R J Armitage, et al.
Immunology Today|November 1, 1993
CD40 ligand and its role in X-linked hyper-IgM syndromeR E Callard, R J Armitage, W C Fanslow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1993
Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokinesR J Armitage, B M Macduff, M K Spriggs, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteinsP R Johnson, M K Spriggs, R A Olmsted, et al.
Journal of Virology|April 1, 1988
Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infectionM K Spriggs, P L Collins, E Tierney, et al.
Virology|July 15, 1986
Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxovirusesM K Spriggs, R A Olmsted, S Venkatesan, et al.
Journal of Virology|November 1, 1987
Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunityM K Spriggs, B R Murphy, G A Prince, et al.
Pageof 6